Operating Lease, Right-of-Use Asset of Kraig Biocraft Laboratories, Inc. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Kraig Biocraft Laboratories, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • Kraig Biocraft Laboratories, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $184,030, a 87% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Kraig Biocraft Laboratories, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $184,030 +$85,364 +87% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $58,426 -$13,421 -19% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $72,568 -$41,459 -36% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $86,088 -$9,720 -10% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 $98,666 -$8,778 -8.2% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $71,847 +$37,033 +106% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $114,027 +$67,073 +143% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $95,808 +$36,959 +63% 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 $107,444 +$36,943 +52% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $34,814 -$47,112 -58% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $46,954 -$46,178 -50% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 $58,849 -$45,275 -43% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $70,501 -$44,405 -39% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $81,926 -$250,288 -75% 30 Jun 2022 10-Q 01 Aug 2022 2022 Q2
Q1 2022 $93,132 -$230,965 -71% 31 Mar 2022 10-Q 06 May 2022 2022 Q1
Q4 2021 $104,124 -$260,901 -71% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 $114,906 -$270,530 -70% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 $332,214 -$83,035 -20% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $324,097 -$120,417 -27% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $365,025 -$108,217 -23% 31 Dec 2020 10-K 16 Mar 2022 2021 FY
Q3 2020 $385,436 -$116,009 -23% 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 $415,249 -$113,886 -22% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $444,514 +$287,384 +183% 31 Mar 2020 10-Q 21 Apr 2020 2020 Q1
Q4 2019 $473,242 +$473,242 31 Dec 2019 10-K 12 Mar 2021 2020 FY
Q3 2019 $501,445 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 $529,135 30 Jun 2019 10-Q 12 Aug 2019 2019 Q2
Q1 2019 $157,130 31 Mar 2019 10-Q 13 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-Q 13 Nov 2019 2019 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.